Sermet Yıldırmış

485 total citations
19 papers, 375 citations indexed

About

Sermet Yıldırmış is a scholar working on Biochemistry, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Sermet Yıldırmış has authored 19 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biochemistry, 5 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Sermet Yıldırmış's work include Phytochemicals and Antioxidant Activities (5 papers), Essential Oils and Antimicrobial Activity (4 papers) and Metabolism and Genetic Disorders (3 papers). Sermet Yıldırmış is often cited by papers focused on Phytochemicals and Antioxidant Activities (5 papers), Essential Oils and Antimicrobial Activity (4 papers) and Metabolism and Genetic Disorders (3 papers). Sermet Yıldırmış collaborates with scholars based in Türkiye, Australia and Cyprus. Sermet Yıldırmış's co-authors include Asım Örem, Orhan Değer, Fazıl Orhan, Alişan Yıldıran, Hatice Aksu, Mustafa Bilici, Fatma Yıldırım, Mehmet Bekaroğlu, Murat Topbaş and Fatma Müjgan Sönmez and has published in prestigious journals such as Clinica Chimica Acta, Urology and The Journal of Membrane Biology.

In The Last Decade

Sermet Yıldırmış

19 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sermet Yıldırmış Türkiye 9 159 87 49 42 36 19 375
Desheng Zhai China 13 65 0.4× 53 0.6× 90 1.8× 46 1.1× 11 0.3× 38 444
Doğan Atılgan Türkiye 15 35 0.2× 47 0.5× 95 1.9× 30 0.7× 39 1.1× 46 522
Janet L. Karlix United States 18 66 0.4× 105 1.2× 181 3.7× 33 0.8× 20 0.6× 36 756
Bekir Süha Parlaktaş Türkiye 14 37 0.2× 43 0.5× 95 1.9× 13 0.3× 28 0.8× 44 488
F Musil Czechia 10 68 0.4× 42 0.5× 46 0.9× 60 1.4× 40 1.1× 39 329
Stefano Turolo Italy 12 73 0.5× 97 1.1× 81 1.7× 49 1.2× 99 2.8× 36 419
Sara Asadi Iran 11 43 0.3× 30 0.3× 57 1.2× 112 2.7× 34 0.9× 32 516
Eberhard Riedel Germany 15 43 0.3× 30 0.3× 77 1.6× 71 1.7× 30 0.8× 62 568
Tomoya Kataoka Japan 13 244 1.5× 16 0.2× 82 1.7× 84 2.0× 23 0.6× 59 527
Ahmet Musmul Türkiye 12 24 0.2× 26 0.3× 79 1.6× 37 0.9× 25 0.7× 58 469

Countries citing papers authored by Sermet Yıldırmış

Since Specialization
Citations

This map shows the geographic impact of Sermet Yıldırmış's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sermet Yıldırmış with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sermet Yıldırmış more than expected).

Fields of papers citing papers by Sermet Yıldırmış

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sermet Yıldırmış. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sermet Yıldırmış. The network helps show where Sermet Yıldırmış may publish in the future.

Co-authorship network of co-authors of Sermet Yıldırmış

This figure shows the co-authorship network connecting the top 25 collaborators of Sermet Yıldırmış. A scholar is included among the top collaborators of Sermet Yıldırmış based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sermet Yıldırmış. Sermet Yıldırmış is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yalazan, Halise, Burak Barut, Can Özgür Yalçın, Halıt Kantekın, & Sermet Yıldırmış. (2024). In vitro cholinesterases, tyrosinase, α-glucosidase inhibitory and anticancer effects of novel silicon phthalocyanines containing geraniol/phytol. Inorganic Chemistry Communications. 165. 112548–112548. 2 indexed citations
2.
3.
Yıldırmış, Sermet, et al.. (2021). Evaluation of biological activities ofBarbarea integrifoliaand isolation of a new glucosinolate derivated compound. Zeitschrift für Naturforschung C. 76(9-10). 375–382. 3 indexed citations
4.
Yıldırmış, Sermet, et al.. (2020). Phenolic Content and Enzyme Inhibition Activities Barbarea auriculata var. paludosa, B. integrifolia and B. plantaginea (Brassicaceae)'s. Journal of Pharmaceutical Research International. 86–93. 3 indexed citations
5.
Demirbaş, Ümit, et al.. (2019). Synthesis, Characterization, and Investigation of Cholinesterase Inhibitory Properties of Novel Phthalocyanines. Journal of Heterocyclic Chemistry. 56(5). 1553–1559. 5 indexed citations
6.
Mercantepe, Tolga, Yıldıray Kalkan, Levent Tümkaya, et al.. (2018). Protective effects of tumor necrosis factor alpha inhibitors on methotrexate-induced pancreatic toxicity. Advances in Clinical and Experimental Medicine. 27(6). 715–720. 8 indexed citations
7.
Yıldırmış, Sermet, et al.. (2016). Biological Activity and Characterization of Volatile Compounds ofTeucrium orientaleVar.glabrescensby SPME and GC-FID/MS. Journal of Food Biochemistry. 41(1). e12284–e12284. 5 indexed citations
8.
Demir, Selim, et al.. (2016). Phenolic Characterisation and Antioxidant Activity of Primula vulgaris and Its Antigenotoxic Effect on Fibroblast Cells. Jundishapur Journal of Natural Pharmaceutical Products. 12(1). 21 indexed citations
9.
Demir, Selim, et al.. (2016). Phenolic Characterisation and Antioxidant Activity of Primula vulgaris and Its Antigenotoxic Effect on Fibroblast Cells. Jundishapur Journal of Natural Pharmaceutical Products. In press(In press). 6 indexed citations
10.
Bostan, Mehmet, Hüseyin Avni Uydu, Sermet Yıldırmış, et al.. (2015). Pleiotropic effects of HDL subfractions and HDL-associated enzymes on protection against coronary artery disease.. PubMed. 70(3). 333–40. 2 indexed citations
11.
Uydu, Hüseyin Avni, Sermet Yıldırmış, Cihan Örem, et al.. (2012). The Effects of Atorvastatin Therapy on Rheological Characteristics of Erythrocyte Membrane, Serum Lipid Profile and Oxidative Status in Patients with Dyslipidemia. The Journal of Membrane Biology. 245(11). 697–705. 32 indexed citations
12.
Aliyazıcıoğlu, Yüksel, Orhan Değer, Caner Karahan, Sermet Yıldırmış, & Ş. Küçüködük. (2007). Reference values of cord blood transferrin, ceruloplasmin, alpha-1 antitrypsin, prealbumin, and alpha-2 macroglobulin concentrations in healthy term newborns.. PubMed. 49(1). 52–4. 5 indexed citations
13.
Sönmez, Fatma Müjgan, Asım Örem, Sermet Yıldırmış, et al.. (2006). Effect of Antiepileptic Drugs on Plasma Lipids, Lipoprotein (a), and Liver Enzymes. Journal of Child Neurology. 21(1). 70–74. 63 indexed citations
14.
Yıldırmış, Sermet, et al.. (2006). Ham’s F-10 medium and Ham’s F-10 medium plus vitamin E have protective effect against oxidative stress in human semen. Urology. 67(2). 384–387. 8 indexed citations
15.
Efe, Hasan, et al.. (2004). Erythrocyte Antioxidant Enzyme Activities and Lipid Peroxidation in Patients with Types IIb and IV Hyperlipoproteinemias. The Tohoku Journal of Experimental Medicine. 202(3). 163–172. 7 indexed citations
16.
Bilici, Mustafa, Fatma Yıldırım, Mehmet Bekaroğlu, et al.. (2003). Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 181–190. 134 indexed citations
17.
Orhan, Fazıl, et al.. (2001). Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood. Journal of Child Neurology. 16(5). 367–369. 37 indexed citations
18.
Orhan, Fazıl, et al.. (2001). Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood. Journal of Child Neurology. 16(5). 364–364. 1 indexed citations
19.
Değer, Orhan, Asım Örem, Nurettin Akyol, Sevgi Bahadır, & Sermet Yıldırmış. (1995). Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease. Clinica Chimica Acta. 236(2). 129–134. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Desheng Zhai Breakdown of academic impact, for papers by Doğan Atılgan Breakdown of academic impact, for papers by Janet L. Karlix Breakdown of academic impact, for papers by Bekir Süha Parlaktaş Breakdown of academic impact, for papers by F Musil Breakdown of academic impact, for papers by Stefano Turolo Breakdown of academic impact, for papers by Sara Asadi Breakdown of academic impact, for papers by Eberhard Riedel Breakdown of academic impact, for papers by Tomoya Kataoka Breakdown of academic impact, for papers by Ahmet Musmul
Rankless by CCL
2026